Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy

The results suggest that high-dose proton beam therapy could control GBM pathogenesis if the treatment area completely covers tumor infiltration. Although radiation necrosis was inevitable, the remaining brain volume was fairly well preserved in the long-term survivors.